Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.
about
The IL-8/IL-8R Axis: A Double Agent in Tumor Immune ResistanceTrial watch: Dendritic cell-based anticancer therapyNeutrophils and Granulocytic MDSC: The Janus God of Cancer ImmunotherapyThe CXCL8-CXCR1/2 pathways in cancerThe Multifaceted Roles Neutrophils Play in the Tumor MicroenvironmentMelanoma-infiltrating dendritic cells: Limitations and opportunities of mouse modelsControl of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Histamine therapeutic efficacy in metastatic melanoma: Role of histamine H4 receptor agonists and opportunity for combination with radiation.Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysisVasculogenic mimicry is associated with increased tumor-infiltrating neutrophil and poor outcome in esophageal squamous cell carcinoma.Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis.Role of plasmacytoid dendritic cells and inducible costimulator-positive regulatory T cells in the immunosuppression microenvironment of gastric cancer.Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanomaNeutrophil-lymphocyte ratio as a predictor of recurrence and progression in patients with high-grade pT1 bladder cancer.Prognostic Impact of Immune Microenvironment in Lung Squamous Cell Carcinoma: Tumor-Infiltrating CD10+ Neutrophil/CD20+ Lymphocyte Ratio as an Independent Prognostic FactorThe wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer.Trial watch: Dendritic cell-based interventions for cancer therapyBroad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.Trial watch: Prognostic and predictive value of the immune infiltrate in cancerAngiotensin converting enzyme inhibitors and angiotensin II receptor antagonist attenuate tumor growth via polarization of neutrophils toward an antitumor phenotypeNeutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx CarcinomaPhorbol ester-induced neutrophilic inflammatory responses selectively promote metastatic spread of melanoma in a TLR4-dependent mannerRole of dendritic cells in the regulation of antitumor immunityTumour-associated CD66b+ neutrophil count is an independent prognostic factor for recurrence in localised cervical cancerB7-H3 associated with tumor progression and epigenetic regulatory activity in cutaneous melanoma.Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node.Lessons from cancer immunoediting in cutaneous melanoma.Microenvironment and tumor progression of melanoma: new therapeutic prospectives.Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer.Plasmacytoid dendritic cells, a role in neoplastic prevention and progression.Modulations in the Peripheral Immune System of Glioblastoma Patient Is Connected to Therapy and Tumor Progression-A Case Report from the IMMO-GLIO-01 Trial.Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma.Melanoma hijacks plasmacytoid dendritic cells to promote its own progression.Neutrophils: important contributors to tumor progression and metastasis.Neutrophils in the Tumor Microenvironment.Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells.Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cells.
P2860
Q26746986-0719DB51-D960-4BE4-93A6-281304EE5827Q27024047-50183D0A-FCA5-4FF7-9AF5-75C544833DEBQ28069360-3C47FCBC-6684-4959-9653-8A413CC4E71AQ28075994-747128A5-C055-4B2A-8433-767F44BEE5F2Q28241308-34688DAD-4D8A-4B52-8380-4259149CA087Q28392156-68FA3D1F-583E-430F-A62F-BE7323375BD3Q29994573-396438C0-3BFF-4A1F-9D63-6080CFE5851BQ30317628-1D65C8B5-2681-4BC2-8D16-20480C9F7DEAQ33688711-58883011-ADD3-47CC-B2AB-E1890A4CD028Q33721221-19D273C4-3CF7-40AD-938A-F6D93812A409Q33813380-1B66CA12-5BF3-4620-8EFA-6D26A74DDF96Q34147688-7D4A82C7-1CED-47C2-88CE-F26AB320D6D1Q35051504-ED1A8B0F-7C38-4CD7-B72A-BD78CDBDCF0FQ35078852-5EA6F5DA-AB4F-4A71-A353-0132B6EFEFF1Q35220302-8F83CB27-DB68-48B8-A4A0-25923BD34D67Q35984951-0B5828B4-7DCD-4634-9510-4F6E3A9421D4Q36098663-8D8D61BE-FCA3-412F-9181-A0238E665B85Q36388529-480D9A06-8375-44B4-AB99-655EF9884124Q36417330-78115859-0006-43BA-AF76-41AC6749DB73Q36456483-31D8FE6D-5CBB-4AEB-BEF0-94253CBB838FQ36597484-B003B6FE-D125-40C6-8D53-7D95929B405CQ36617155-9D2F8F22-0FE2-448C-A8A7-FEEB90BD6C69Q36711023-4148E4B8-9F4F-4D26-A897-52905ECB596BQ36845842-90381643-FD16-41F4-A751-3A2AB8C17C49Q36896309-5FFC301D-48B2-43F2-82B4-EC3C014D21AAQ37140050-93F8C9AA-389F-41EB-9F38-A79E06C05D6DQ37289626-C402DB7F-4F87-4F19-B68A-5C7EF1343612Q37442008-E21CF75F-2827-4FD5-942E-BB9097C35D23Q38038176-4A8A6E89-9237-450C-8E63-6A680D90527CQ38049368-D724AC19-313E-4E91-8D72-9CE4323222BCQ38166232-77E3EFDD-ED3A-487A-A7D4-E9D430EA8672Q38294189-23B1EEAD-4EF1-4ED6-A858-44D165A47216Q38374300-22DC513F-E655-4EF5-A36F-939E906A12AAQ38394496-90E93744-BEDA-4339-A24C-C4F6AD70C59CQ38400790-58C63D13-2B77-45FA-B52B-3352C709281DQ38585102-0AB2E02E-5ECC-4CA1-BAFE-4FC5F74EE8E2Q38678088-429AF776-B43F-4928-ADCE-FB304F06DC5CQ38688789-EE890F75-6213-44E9-A367-B5B003C6C143Q38705015-FECCF7D9-5E5B-43DA-B66B-12D965A2568CQ38853116-40CE415E-8C40-4BA5-9B6E-194244487CC9
P2860
Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Intratumoral neutrophils and p ...... n in AJCC stage I/II melanoma.
@en
Intratumoral neutrophils and p ...... n in AJCC stage I/II melanoma.
@nl
type
label
Intratumoral neutrophils and p ...... n in AJCC stage I/II melanoma.
@en
Intratumoral neutrophils and p ...... n in AJCC stage I/II melanoma.
@nl
prefLabel
Intratumoral neutrophils and p ...... n in AJCC stage I/II melanoma.
@en
Intratumoral neutrophils and p ...... n in AJCC stage I/II melanoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Intratumoral neutrophils and p ...... on in AJCC stage I/II melanoma
@en
P2093
Henrik Schmidt
Ib J Christensen
Pia Sjoegren
Trine O Jensen
P2860
P304
P356
10.1002/CNCR.26511
P407
P577
2011-09-22T00:00:00Z